Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage.
Recent studies report a prevalence of non-alcoholic fatty liver disease (NAFLD) of between 70% and 80% in patients with metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM). Nevertheless, it is not possible to differentiate between simple steatosis and non-alcoholic steatohepatitis (NASH) wit...
| Published in: | PLoS ONE |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Online Access: | http://europepmc.org/articles/PMC5453539?pdf=render |
